OpenURL Connection Search

Select item for more details and to access through your institution.

Inversion de l'espace et du temps des processus de Lévy stables.
Published in:
Probability Theory & Related Fields, 2006, v. 135, n. 2, p. 201, doi. 10.1007/s00440-005-0455-2
By:
- Fourati, S.
Publication type:
Article
Points de croissance des processus de Lévy et théorie générale des processus.
Published in:
Probability Theory & Related Fields, 1998, v. 110, n. 1, p. 13, doi. 10.1007/s004400050143
By:
- Fourati, S.
Publication type:
Article
Oral ivermectin for a scabies outbreak in a long‐term care facility: potential value in preventing COVID‐19 and associated mortality.
Published in:
British Journal of Dermatology, 2021, v. 184, n. 6, p. 1207, doi. 10.1111/bjd.19821
By:
- Bernigaud, C.;
- Guillemot, D.;
- Ahmed‐Belkacem, A.;
- Grimaldi‐Bensouda, L.;
- Lespine, A.;
- Berry, F.;
- Softic, L.;
- Chenost, C.;
- Do‐Pham, G.;
- Giraudeau, B.;
- Fourati, S.;
- Chosidow, O.
Publication type:
Article
Negative tests for SARS‐CoV‐2 infection do not rule out its responsibility for chilblains: reply from the authors.
Published in:
British Journal of Dermatology, 2020, v. 183, n. 6, p. 1151, doi. 10.1111/bjd.19486
By:
- Le Cleach, L.;
- Fourati, S.;
- Sbidian, E.;
- Beylot‐Barry, M.
Publication type:
Article
Most chilblains observed during the COVID‐19 outbreak occur in patients who are negative for COVID‐19 on polymerase chain reaction and serology testing*.
Published in:
British Journal of Dermatology, 2020, v. 183, n. 5, p. 866, doi. 10.1111/bjd.19377
By:
- Le Cleach, L.;
- Dousset, L.;
- Assier, H.;
- Fourati, S.;
- Barbarot, S.;
- Boulard, C.;
- Bourseau Quetier, C.;
- Cambon, L.;
- Cazanave, C;
- Colin, A.;
- Kostrzewa, E.;
- Lesort, C.;
- Levy Roy, A.;
- Lombart, F.;
- Marco‐Bonnet, J.;
- Monfort, J.‐B.;
- Samimi, M.;
- Tardieu, M.;
- Wolkenstein, P.;
- Sbidian, E.
Publication type:
Article
Beyond the First Year: Epidemiology and Management of Late-Onset Opportunistic Infections After Kidney Transplantation.
Published in:
Transplant International, 2024, p. 1, doi. 10.3389/ti.2024.12065
By:
- Esnault, V.;
- Hoisnard, L.;
- Peiffer, B.;
- Fihman, V.;
- Fourati, S.;
- Angebault, C.;
- Champy, C.;
- Gallien, S.;
- Attias, P.;
- Morel, A.;
- Grimbert, P.;
- Melica, G.;
- Matignon, M.
Publication type:
Article
Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Published in:
HIV Medicine, 2015, v. 16, n. 9, p. 553, doi. 10.1111/hiv.12257
By:
- Hattab, S;
- Guiguet, M;
- Carcelain, G;
- Fourati, S;
- Guihot, A;
- Autran, B;
- Caby, F;
- Marcelin, A‐G;
- Costagliola, D;
- Katlama, C
Publication type:
Article
Retrospective study on the association of human herpesvirus reactivation with severe DRESS: A description of blood and skin reactivations.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 12, p. 2550, doi. 10.1111/jdv.19425
By:
- Marcombes, C.;
- Ingen‐Housz‐Oro, S.;
- Dezoteux, F.;
- Staumont‐Sallé, D.;
- Milpied, B.;
- Tetart, F.;
- de Prost, N.;
- Fourati, S.;
- Ortonne, N.;
- Kasimir, F.;
- Prusty, B. K.;
- Descamps, V.
Publication type:
Article
Non‐acral skin manifestations during the COVID‐19 epidemic: COVIDSKIN study by the French Society of Dermatology.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2021, v. 35, n. 9, p. e539, doi. 10.1111/jdv.17322
By:
- Guelimi, R.;
- Salle, R.;
- Dousset, L.;
- Assier, H.;
- Fourati, S.;
- Bhujoo, Z.;
- Barbarot, S.;
- Boulard, C.;
- Cazanave, C.;
- Colin, A.;
- Kostrzewa, E.;
- Lesort, C.;
- Levy Roy, A.;
- Lombart, F.;
- Marco Bonnet, J.;
- Marty, L.;
- Monfort, J.B.;
- Riffaud, L.;
- Samimi, M.;
- Tardieu, M.
Publication type:
Article
Editorial: are additional tests needed to predict sustained virologic response in hepatitis C treated with interferon‐free direct‐acting antiviral combinations? Authors’ reply.
Published in:
2018
By:
- Fourati, S.;
- Pawlotsky, J.‐M.
Publication type:
Letter to the Editor
Viral kinetics analysis and virological characterization of treatment failures in patients with chronic hepatitis C treated with sofosbuvir and an NS5A inhibitor.
Published in:
Alimentary Pharmacology & Therapeutics, 2018, v. 47, n. 5, p. 665, doi. 10.1111/apt.14478
By:
- Fourati, S.;
- Guedj, J.;
- Chevaliez, S.;
- Nguyen, T. H. T.;
- Roudot‐Thoraval, F.;
- Ruiz, I.;
- Soulier, A.;
- Scoazec, G.;
- Varaut, A.;
- Poiteau, L.;
- Francois, M.;
- Mallat, A.;
- Hézode, C.;
- Pawlotsky, J.‐M.
Publication type:
Article
Rapid plasma viral suppression in naive HIV-infected patients with high CD4 cells and low viraemia initiating a dual nucleoside reverse transcriptase inhibitor strategy: a proof-of-concept study.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 12, p. 3356, doi. 10.1093/jac/dku265
By:
- Seang, S.;
- Fourati, S.;
- Keita, Y.;
- Blanc, C.;
- Tubiana, R.;
- Schneider, L.;
- Valantin, M. A.;
- Caby, F.;
- Calin, R.;
- Lambert-Niclot, S.;
- Marcelin, A.-G.;
- Calvez, V.;
- Costagliola, D.;
- Katlama, C.
Publication type:
Article
High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
Published in:
2014
By:
- Fofana, D B;
- Soulié, C;
- Baldé, A;
- Lambert-Niclot, S;
- Sylla, M;
- Ait-Arkoub, Z;
- Diallo, F;
- Sangaré, B;
- Cissé, M;
- Maïga, I A;
- Fourati, S;
- Koita, O;
- Calvez, V;
- Marcelin, A G;
- Maïga, A I
Publication type:
Journal Article
High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 9, p. 2531, doi. 10.1093/jac/dku153
By:
- Fofana, D. B.;
- Soulié, C.;
- Baldé, A.;
- Lambert-Niclot, S.;
- Sylla, M.;
- Ait-Arkoub, Z.;
- Diallo, F.;
- Sangaré, B.;
- Cissé, M.;
- Maïga, I. A.;
- Fourati, S.;
- Koita, O.;
- Calvez, V.;
- Marcelin, A. G.;
- Maïga, A. I.
Publication type:
Article
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.
Published in:
2014
By:
- Lambert-Niclot, S;
- Charpentier, C;
- Storto, A;
- Fofana, D;
- Soulie, C;
- Fourati, S;
- Wirden, M;
- Morand-Joubert, L;
- Masquelier, B;
- Flandre, P;
- Calvez, V;
- Descamps, D;
- Marcelin, A G
Publication type:
Journal Article
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2014, v. 69, n. 4, p. 1086, doi. 10.1093/jac/dkt463
By:
- Lambert-Niclot, S.;
- Charpentier, C.;
- Storto, A.;
- Fofana, D.;
- Soulie, C.;
- Fourati, S.;
- Wirden, M.;
- Morand-Joubert, L.;
- Masquelier, B.;
- Flandre, P.;
- Calvez, V.;
- Descamps, D.;
- Marcelin, A. G.
Publication type:
Article
Genetic barrier to the development of resistance to rilpivirine and etravirine between HIV-1 subtypes CRF02_AG and B.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 11, p. 2515, doi. 10.1093/jac/dkt251
By:
- Fofana, D. B.;
- Soulie, C.;
- Maiga, A. I.;
- Fourati, S.;
- Malet, I.;
- Wirden, M.;
- Tounkara, A.;
- Traore, H. A.;
- Calvez, V.;
- Marcelin, A. G.;
- Lambert-Niclot, S.
Publication type:
Article
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
Published in:
Journal of Antimicrobial Chemotherapy (JAC), 2013, v. 68, n. 6, p. 1237, doi. 10.1093/jac/dkt003
By:
- Lambert-Niclot, S.;
- Charpentier, C.;
- Storto, A.;
- Fofana, D. B.;
- Soulié, C.;
- Fourati, S.;
- Visseaux, B.;
- Wirden, M.;
- Morand-Joubert, L.;
- Masquelier, B.;
- Flandre, P.;
- Calvez, V.;
- Descamps, D.;
- Marcelin, A.-G.
Publication type:
Article

Found: 18